Spots Global Cancer Trial Database for Will Preoperative MRI Breast in Women Under 56 Years With Breast Cancer Change Primary Treatment

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Will Preoperative MRI Breast in Women Under 56 Years With Breast Cancer Change Primary Treatment

Official Title: Randomized Multicenter Trial Assessing if Preoperative MRI Breast in Women Under 56 Years With Breast Cancer Will Change Primary Treatment

Study ID: NCT01859936

Conditions

Breast Neoplasm

Interventions

MRI

Study Description

Brief Summary: The study is a prospective randomised multicenter trial assessing the additional value of breast MRI in women under 56 years of age with newly diagnosed breast cancer. Will preoperative breast MRI change treatment regimen? Will preoperative breast MRI reduce the number of primary surgeries? Will preoperative breast MRI increase the rate of mastectomies? Will preoperative breast MRI be cost effective?

Detailed Description: Completed: the study has concluded normally; participants are no longer being examined or treated (i.e., last patient's last visit has occurred)